Disclosure Plus

COPUS KOREA Co., Ltd. Decides to Issue 17.5 Billion Won in Convertible Bonds

Park Jung-Soo
2026-06-29 09:58:57
[Edaily Reporter Park Jung-Soo ] COPUS KOREA Co., Ltd.(322780)announced on the 29th that it has decided to issue its fifth series of bearer, non-cumulative, unsecured private placement convertible bonds (CBs) worth 17.5 billion won. The CB issuance is intended to raise working capital (15.4467 billion won) and funds for debt repayment (2.0533 billion won). There is no coupon rate or maturity interest rate. The bonds are convertible into registered common stock of COPUS KOREA Co., Ltd., with a total of 9,743,875 shares. The conversion price is 1,796 won, and the conversion ratio is 100%. The bond maturity date is July 24, 2031. The conversion period runs from July 24, 2027, to June 24, 2031.

Economy

Corporation

IT·Science

Economy

[VC's Pick] Big Money Flows into Smart 'Medical AI and Robotics' Technologies That Replace Human Hands

This week (November 16–20), startups in various fields—including robotics, image analysis, and business platforms—secured investments from venture capital (VC) firms and accelerators (ACs). In particu…
2026-11-21 10:04:03

Corporation

Celltrion Sees Full-Scale Results from Direct Sales in the U.S. … “Projected Operating Profit of 2.4 Trillion Won Next Year”

Celltrion(068270)Forecasts indicate that Celltrion will continue its steep earnings growth as it expands its direct sales performance in the U.S. biosimilar market. Expectations for a revaluation of t…
2026-11-21 06:01:02

IT·Science

Penetrium Bioscience and AprilBio Rally as AriBio-Linked Stocks Diverge [K-Bio Pulse]

South Korean pharmaceutical and biotechnology stocks posted mixed results on November 19, driven by clinical trial developments and expectations regarding their inclusion in major stock indices. Penet…
2026-11-21 08:17:02